| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/17/2012 | CA2373290C Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms |
| 04/17/2012 | CA2355495C Method of modulating tumor immunity |
| 04/17/2012 | CA2347928C Cell surface molecule-induced macrophage activation |
| 04/17/2012 | CA2145778C Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| 04/12/2012 | WO2012048316A2 Regulators of nfat and/or store-operated calcium entry |
| 04/12/2012 | WO2012047956A2 Treatment of sialidase 4 (neu4) related diseases by inhibition of natural antisense transcript to neu4 |
| 04/12/2012 | WO2012047679A2 Consensus antigen constructs and vaccines made there form, and methods of using same to treat malaria |
| 04/12/2012 | WO2012047287A2 Upregulation of opioid receptors for pain management |
| 04/12/2012 | WO2012047091A1 Glp-1 promoter mediated insulin expression for the treatment of diabetes |
| 04/12/2012 | WO2012046943A2 Gene delivery system having enhanced tumor-specific expression, and recombinant gene expression regulating sequence |
| 04/12/2012 | WO2012046874A1 Method for evaluating degree of cancerization |
| 04/12/2012 | WO2012046873A1 Method for evaluating degree of cancerization |
| 04/12/2012 | WO2012046872A1 Method for evaluating degree of cancerization |
| 04/12/2012 | WO2012046871A1 Method for evaluating degree of cancerization |
| 04/12/2012 | WO2012046730A1 Method for activating helper t cell |
| 04/12/2012 | WO2012046727A1 Method for producing virus vector |
| 04/12/2012 | WO2012046006A2 Cancer targets |
| 04/12/2012 | WO2012045894A1 Compounds and compositions for the treatment of illnesses caused by the hepatitis b virus |
| 04/12/2012 | WO2012045797A1 Lipothiophosphoramidates for gene delivery |
| 04/12/2012 | WO2012045286A1 Recombinant vector and fibroin membrane modified by transgenic bone stromal cell, and application thereof |
| 04/12/2012 | WO2011163499A3 Treatment of sodium channel, voltage-gated, alpha subunit (scna) related diseases by inhibition of natural antisense transcript to scna |
| 04/12/2012 | WO2011152884A9 14 gene signature distinguishes between multiple myeloma subtypes |
| 04/12/2012 | WO2011133424A3 Genetic amplification of iqgap1 in cancer |
| 04/12/2012 | WO2011127291A3 Compositions and methods for the treatment of a neoplasia |
| 04/12/2012 | WO2011082281A3 Treatment of insulin receptor substrate 2 (irs2) related diseases by inhibition of natural antisense transcript to irs2 and transcription factor e3 (tfe3) |
| 04/12/2012 | US20120088297 Mycobacterial antigens expressed under low oxygen tension |
| 04/12/2012 | US20120087931 Therapeutic and diagnostic anti-hsp70 antibodies |
| 04/12/2012 | US20120087918 Methods and compositions for inhibiting the growth of hematopoietic malignant cells |
| 04/12/2012 | US20120087909 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 04/12/2012 | DE10237517B4 Verfahren zur An- bzw. Abreicherung von Biomolekülen aus flüssigen oder fluiden Medien unter Verwendung von Schichtdoppelhydroxiden und Verwendung von an einem Schichtdoppelhydroxid an- oder eingelagerten Biomolekülen als anorganischer Vektor A method for enrichment or depletion of biomolecules from liquid or fluid media using Schichtdoppelhydroxiden and use of other on a layered double or embedded biomolecules as inorganic Vector |
| 04/12/2012 | CA2813901A1 Treatment of sialidase 4 (neu4) related diseases by inhibition of natural antisense transcript to neu4 |
| 04/12/2012 | CA2813557A1 Method for activating helper t cell |
| 04/12/2012 | CA2812789A1 Consensus antigen constructs and vaccines made therefrom, and methods of using same to treat malaria |
| 04/11/2012 | EP2439274A2 MULTI-CISTRONIC shRNA EXPRESSION CASSETTE FOR SUPPRESSING SINGLE OR MULTIPLE TARGET GENES |
| 04/11/2012 | EP2438931A1 Improved expression of factor IX in gene therapy vectors |
| 04/11/2012 | EP2438816A2 Improved modalities for the treatment of degenerative diseases of the retina |
| 04/11/2012 | EP2438815A2 Improved modalities for the treatment of degenerative diseases of the retina |
| 04/11/2012 | EP2438814A2 Improved modalities for the treatment of degenerative diseases of the retina |
| 04/11/2012 | EP2438167A1 Therapeutic and diagnostic molecules |
| 04/11/2012 | EP2438079A2 Nucleic acid delivery compositions and methods of use thereof |
| 04/11/2012 | EP2437791A2 Potentiation of autoimmune and inflammatory disease treatments by immune regulatory oligonucleotide (iro) antagonists of tlr7 and tlr9 |
| 04/11/2012 | EP2437749A2 Interlaced method for treating cancer or a precancerous condition |
| 04/11/2012 | EP2126078B1 Composition and methods for modulating cell proliferation and cell death |
| 04/11/2012 | EP1989299B1 Meganuclease variants cleaving a dna target sequence from a xeroderma pigmentosum gene and uses thereof |
| 04/11/2012 | EP1970075B1 THERAPEUTIC AGENT FOR NEUROBLASTOMA TARGETING ARID3b |
| 04/11/2012 | EP1594964B1 Oligonucleotides which inhibit the expression of the ob-rgrp protein and method for detection of compounds modifying the interaction between the proteins of the ob-rgrp family and the leptin receptor |
| 04/11/2012 | EP1377596B1 Ttk in diagnosis and as a therapeutic target in cancer |
| 04/11/2012 | EP1341909B2 A method for in vitro molecular evolution of protein function |
| 04/11/2012 | EP1235912B1 Tumour-specific vector for gene therapy |
| 04/11/2012 | EP1125947B1 Human H37 protein and cDNA encoding the same |
| 04/11/2012 | EP1071804B1 Use of triplex structure dna sequences for transferring nucleotide sequences |
| 04/11/2012 | CN102409063A 黄病毒ns1亚单位疫苗 Flavivirus ns1 subunit vaccine |
| 04/11/2012 | CN102409054A 多发性骨髓瘤的rna干扰靶点序列及其应用 Rna interference of multiple myeloma target sequence and its application |
| 04/11/2012 | CN102408498A 一种透明质酸键合聚乙烯亚胺共聚物、其制备方法及应用 One kind of hyaluronic acid bonded polyethyleneimine copolymer, its preparation method and application |
| 04/11/2012 | CN102408488A Quaternary ammonium type cationic starch gene controlled release vector material and preparation method and application thereof |
| 04/11/2012 | CN102408472A 一种Bt蛋白Cry62Aa1、其编码基因及应用 One kind of Bt protein Cry62Aa1, its coding gene and application |
| 04/11/2012 | CN102406948A Constructing method of recombinant DNA (deoxyribonucleic acid) nucleic acid vaccine of vibrio alginolyticus HSP70 |
| 04/11/2012 | CN102406947A 微RNA-34a在制备抗肿瘤药物中的用途 Micro-RNA-34a for the preparation of anticancer drugs |
| 04/11/2012 | CN101716351B 一类吡啶化合物在制备rna干涉增强剂中的应用 Pyridine compounds in the preparation of a class of rna interference enhancer Application |
| 04/10/2012 | US8153778 RNA interference mediated inhibition of vascular cell adhesion molecule (VCAM) gene expression using short interfering nucleic acid (siNA) |
| 04/10/2012 | US8153777 Modulation of toll-like receptor 5 expression by antisense oligonucleotides |
| 04/10/2012 | US8153776 Using targeted gene expression inhibition to treat and prevent viral infection |
| 04/10/2012 | US8153608 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 04/10/2012 | US8153603 Compositions and their uses directed to IL-4R alpha |
| 04/10/2012 | US8153602 Composition and methods for the pulmonary delivery of nucleic acids |
| 04/10/2012 | US8153585 Peptide antagonists of vascular endothelial growth factor and methods of use thereof |
| 04/10/2012 | US8153580 Nogo receptor binding protein |
| 04/10/2012 | US8153422 Dopaminergic neurons differentiated from embryonic cells for treating neurodegenerative diseases |
| 04/10/2012 | US8153402 Emulsion compositions |
| 04/10/2012 | US8153400 Nucleic acids encoding a mutT domain-containing polypeptide |
| 04/10/2012 | US8153384 Marks as modifiers of the p53 pathway and methods of use |
| 04/10/2012 | US8153364 Emulsion compositions |
| 04/10/2012 | US8153141 Immunostimulatory G, U-containing oligoribonucleotides |
| 04/10/2012 | US8153138 Recombinant MVA virus |
| 04/10/2012 | US8153129 Antibodies against human cytimegalovirus (HCMV) |
| 04/10/2012 | US8153117 Genetically altered chondrocyte expresses a therapeutic agent; implanting a biocompatible substrate into a target region; brain, heart, liver, kidney, intestinal tract, spleen, smooth and skeletal muscles, eye, ganglions, lungs, gonads, pancreas |
| 04/10/2012 | US8153113 Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue |
| 04/10/2012 | CA2598893C Eml4-alk fusion gene |
| 04/10/2012 | CA2567867C Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation |
| 04/10/2012 | CA2537861C Entrapped stem cells and uses thereof |
| 04/10/2012 | CA2534349C Human skin equivalents expressing exogenous polypeptides |
| 04/10/2012 | CA2468496C Ilk inhibitors for the treatment of renal disease |
| 04/10/2012 | CA2385325C Chlamydia antigens and corresponding dna fragments and uses thereof |
| 04/10/2012 | CA2353086C Pgc-1, a novel brown fat ppar.gamma. coactivator |
| 04/10/2012 | CA2352783C Stimulation of t cells against self antigens using ctla-4 blocking agents |
| 04/10/2012 | CA2330660C Muscle-derived cell mediated gene delivery for treating muscle-and bone-related injury or dysfunction |
| 04/10/2012 | CA2263503C Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same |
| 04/05/2012 | WO2012045067A2 Mammalian genes involved in infection |
| 04/05/2012 | WO2012044620A2 Modulation of timp1 and timp2 expression |
| 04/05/2012 | WO2012043710A1 GROWTH-REGULATED VIRAL VECTOR CONTAINING THE Aurora KINASE PROMOTER |
| 04/05/2012 | WO2012043633A1 Inhibitor of expression of dominantly mutated gene |
| 04/05/2012 | WO2012042289A1 Methods and pharmaceutical compositions for the treatment of bone density related diseases |
| 04/05/2012 | WO2012041867A2 Combined antigen and dna vaccine for preventing and treating autoimmune diseases |
| 04/05/2012 | WO2012041328A1 Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain |
| 04/05/2012 | WO2012040832A1 Immunomodulatory nucleic acid composition comprising chitosan nanoparticles |
| 04/05/2012 | WO2012006551A3 Neuroprotective molecules and methods of treating neurological disorders and inducing stress granules |
| 04/05/2012 | WO2011153287A3 Materials and methods for diagnosing and predicting the course of prostate cancer |
| 04/05/2012 | WO2011150007A3 Treatment of methionine sulfoxide reductase a (msra) related diseases by inhibition of natural antisense transcript to msra |
| 04/05/2012 | WO2011150005A3 Treatment of atonal homolog 1 (atoh1) related diseases by inhibition of natural antisense transcript to atoh1 |
| 04/05/2012 | WO2011146674A3 Treatment of bcl2-like 11 (bcl2l11) related diseases by inhibition of natural antisense transcript to bcl2l11 |